Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline
- PMID: 37408055
- PMCID: PMC10324255
- DOI: 10.1186/s13014-023-02300-w
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline
Abstract
Purpose: Radiotherapy is, with surgery, one of the main therapeutic treatment strategies for meningiomas. No prospective study has defined a consensus for the delineation of target volumes for meningioma radiotherapy. Therefore, target volume definition is mainly based on information from retrospective studies that include heterogeneous patient populations. The aim is to describe delineation guidelines for meningioma radiotherapy as an adjuvant or definitive treatment with intensity-modulated radiation therapy and stereotactic radiation therapy techniques. This guideline is based on a consensus endorsed by a multidisciplinary group of brain tumor experts, members of the Association of French-speaking Neuro-oncologists (ANOCEF).
Materials and methods: A 3-step procedure was used. First, the steering group carried out a comprehensive review to identify divergent issues on meningiomas target volume delineation. Second, an 84-item web-questionnaire has been developed to precisely define meningioma target volume delineation in the most common clinical situations. Third, experts members of the ANOCEF were requested to answer. The first two rounds were completed online. A third round was carried out by videoconference to allow experts to debate and discuss the remaining uncertain questions. All questions remained in a consensus.
Results: Limits of the target volume were defined using visible landmarks on computed tomography and magnetic resonance imaging, considering the pathways of tumor extension. The purpose was to develop clear and precise recommendations on meningiomas target volumes.
Conclusion: New recommendations for meningiomas delineation based on simple anatomic boundaries are proposed by the ANOCEF. Improvement in uniformity in target volume definition is expected.
Keywords: Consensus guidelines; Delineation; Meningiomas; Radiotherapy; Target volume.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas.Int J Radiat Oncol Biol Phys. 2025 May 1;122(1):150-158. doi: 10.1016/j.ijrobp.2024.12.003. Epub 2024 Dec 19. Int J Radiat Oncol Biol Phys. 2025. PMID: 39701546
-
68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas.Radiat Oncol. 2021 Aug 16;16(1):151. doi: 10.1186/s13014-021-01875-6. Radiat Oncol. 2021. PMID: 34399805 Free PMC article.
-
Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):277-83. doi: 10.1016/j.ijrobp.2010.10.078. Epub 2011 Feb 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 21300465
-
Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.Strahlenther Onkol. 2006 Nov;182(11):635-40. doi: 10.1007/s00066-006-1548-2. Strahlenther Onkol. 2006. PMID: 17072520 Review.
-
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues.Neurosurg Rev. 2022 Oct;45(5):3019-3033. doi: 10.1007/s10143-022-01806-3. Epub 2022 Jun 4. Neurosurg Rev. 2022. PMID: 35665867 Free PMC article. Review.
Cited by
-
Radioligand therapies in meningioma: Evidence and future directions.Neuro Oncol. 2024 Dec 9;26(Supplement_9):S215-S228. doi: 10.1093/neuonc/noae069. Neuro Oncol. 2024. PMID: 38702966 Free PMC article. Review.
-
New imaging findings of tumor invasion into brain tissue: "Peritumoral Hyperintense Enhancement Sign".Front Hum Neurosci. 2025 May 13;19:1592543. doi: 10.3389/fnhum.2025.1592543. eCollection 2025. Front Hum Neurosci. 2025. PMID: 40432979 Free PMC article.
-
Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation.Front Oncol. 2025 Jan 28;15:1474590. doi: 10.3389/fonc.2025.1474590. eCollection 2025. Front Oncol. 2025. PMID: 39935829 Free PMC article.
-
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck.Radiat Oncol J. 2024 Mar;42(1):17-31. doi: 10.3857/roj.2023.00899. Epub 2024 Mar 14. Radiat Oncol J. 2024. PMID: 38549381 Free PMC article.
References
-
- Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neurooncology. 2017;19(suppl5):v1–v88. doi: 10.1093/neuonc/nox158. - DOI - PMC - PubMed
-
- CBTRUS. Statistical report: Primary Brain Tumors in the United States, 1998–2002. 2005.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources